American Research & Management Co. Acadia Pharmaceuticals Inc Transaction History
American Research & Management Co.
- $362 Million
- Q3 2022
A detailed history of American Research & Management Co. transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, American Research & Management Co. holds 100 shares of ACAD stock, worth $1,559. This represents 0.0% of its overall portfolio holdings.
Number of Shares
100
Previous 100
-0.0%
Holding current value
$1,559
Previous $1,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding ACAD
# of Institutions
299Shares Held
158MCall Options Held
1.88MPut Options Held
688K-
Baker Bros. Advisors LP New York, NY42.9MShares$668 Million10.04% of portfolio
-
Rtw Investments, LP New York, NY13.8MShares$216 Million4.1% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.3MShares$207 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.7MShares$182 Million0.01% of portfolio
-
State Street Corp Boston, MA6MShares$93.6 Million0.01% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $2.52B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...